{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T09:25:13Z","timestamp":1772616313695,"version":"3.50.1"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223500\/Z\/21\/Z"],"award-info":[{"award-number":["223500\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Asymptomatic lymphocytosis poses a common challenge in haematology. Immunophenotyping can establish whether a clonal population is present, but it is expensive and the benefit of diagnosing asymptomatic patients is unproven. This study aimed to establish data to guide the use of immunophenotyping. We analysed the proportion of lymphocytosis in full blood count (FBC) samples across a five\u2010year period within a large UK National Health Service (NHS) trust. Persistent lymphocytosis was present in 0.18% (437\/242678) of repeat community samples. Of samples sent for immunophenotyping, 743\/784 (95%) with a lymphocyte count &gt;\u200910\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L had a clonal population, compared to 223\/1696 (14%) with a lymphocyte count &lt;\u20095\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L. We followed up a longitudinal cohort of asymptomatic patients with clonal lymphocytosis to determine how many required treatment. The minority (11\/46) of patients needed treatment within 9\u2009years of follow\u2010up. Of patients needing treatment, 10\/11 (91%) had a presenting lymphocyte count &gt;\u200910\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L. In all cases, treatment was initiated when the patient became symptomatic. We propose a lymphocyte count threshold of &gt;\u200910\u2009\u00d7\u200910<jats:sup>9<\/jats:sup>\/L for referral and immunophenotyping in patients with asymptomatic lymphocytosis. This approach aims to balance safety and cost\u2010effectiveness and reflects uncertainty in the value of diagnosis for asymptomatic patients.<\/jats:p>","DOI":"10.1111\/ejh.14336","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T12:05:52Z","timestamp":1730721952000},"page":"303-309","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immunophenotyping for the Assessment of Asymptomatic Lymphocytosis: A Retrospective Analysis and National Survey"],"prefix":"10.1111","volume":"114","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-6395-7486","authenticated-orcid":false,"given":"Tanya","family":"Freeman","sequence":"first","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Johnstone","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen P.","family":"Hibbs","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"},{"name":"Queen Mary University  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esubalew","family":"Assefa","sequence":"additional","affiliation":[{"name":"Queen Mary University  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shamzah","family":"Araf","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Farren","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Butler","sequence":"additional","affiliation":[{"name":"Barts Health NHS Trust  London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2007.01.014"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000890"},{"issue":"15","key":"e_1_2_10_4_1","first-page":"1702","article-title":"Progression and Survival of MBL: A Screening Study of 10 139 Individuals","volume":"140","author":"Slager S. L.","year":"2022","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa075290"},{"issue":"25","key":"e_1_2_10_6_1","first-page":"2745","article-title":"iwCLL Guidelines for Diagnosis, Indications for Treatment, Response Assessment, and Supportive Management of CLL","volume":"131","author":"Hallek M.","year":"2018","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"e_1_2_10_7_1","unstructured":"https:\/\/ukhealthdata.org\/members\/barts\u2010health\u2010nhs\u2010trust\/."},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802251787"},{"key":"e_1_2_10_9_1","first-page":"93","article-title":"Population Screening for B\u2010Cell Monoclonal Lymphocytosis Using PCR and Flow Cytometry to Determine Immunophenotypes","author":"Jack A.","year":"1997","journal-title":"Proceedings of a USPHS Workshop on Laboratory Approaches to Determining the Role of Environmental Exposures as Risk Factors for B\u2010Cell Chronic Lymphocytic Leukemia and Other B\u2010Cell Lymphoproliferative Disorders"},{"issue":"18","key":"e_1_2_10_10_1","first-page":"4188","article-title":"B\u2010Cell Count and Survival: Differentiating Chronic Lymphocytic Leukemia From Monoclonal B\u2010Cell Lymphocytosis Based on Clinical Outcome","volume":"113","author":"Shanafelt T. D.","year":"2009","journal-title":"Blood, the Journal of the American Society of Hematology"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2263-1"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2010.030189"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.20"},{"key":"e_1_2_10_14_1","unstructured":"https:\/\/www.england.nhs.uk\/publication\/2023\u201025\u2010nhs\u2010payment\u2010scheme\/."},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3277"}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.14336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T13:53:20Z","timestamp":1737467600000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.14336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1111\/ejh.14336"],"URL":"https:\/\/doi.org\/10.1111\/ejh.14336","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"2024-07-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}